The objective of this study was to predict malaria risk and utilization of health care services among the population in Uganda. Methods: We used a retrospective longitudinal study design that involved a secondary analysis of data from Ministry of Health (MoH) and Uganda Bureau of statistics (UBOS).The predicting model was derived taking limiting distribution of the partial derivative with respect to time of the malaria predicting model at the health facilities.
For more reading follow us @http://bit.ly/2hEccoR
Giving off own their carbon dioxide is one of the ways that attract mosquitoes towards us. It signals dinner-time is here!, A female #mosquito who detects CO2 in the air will buzz around in that area until she traces the wafting gas back to its original source.
For more reading follow us @ http://bit.ly/2vPq6L9
Scientists from NIH’s National Institute of Allergy and Infectious Diseases developed the model, which was claiming that mice easily defending against Zika virus better than people because they have a substantial interferon response. Interferon is a powerful antiviral protein that inhibits the virus. The researchers suppressed the interferon in specialized laboratory mice that also lack the ability to produce T cells or B cells.
Let us share our thoughts @ http://bit.ly/2vPq6L9
Mosquitoes of Aedes sps are responsible for Zika virus infected disease. Most people whom anywhere suffering from Zika virus which continues skin rashes, mild fever, conjunctivitis, joint and muscle pain and other peripheral complications. Eventually, these symptoms predominance last for two to seven days. Avoiding mosquito’s bites are the best possible way to avoid this infection. The virus shows it bitter tooth on partial tropical parts of the Americas, Africa, Pacific, tropical parts of Asia. Indian vaccine company, Bharat Biotech makes us proud by developing world first Zika vaccine ZIKAVAC©.
This manuscript is an outgrowth of my discovery of the viroids in 1971, which has been endorsed by the International Committee for the Taxonomy of Viruses (ICTV) as a new order called Subviral Agents, which now consists of two families and upward of 40 species, all isolated from higher plants. Most of these cause diseases of various crops. fruit trees, or ornamental plants. Here I ask the question why, so far, these plant viroids are not complemented by their counterparts in animals.
For more reading follow us @ http://www.scitechnol.com/peer-review/on-the-existence-of-animal-viroids-5pwI.php?article_id=5487
Journal home page: http://www.scitechnol.com/virology-antiviral-research.php
Vector Ecology has a primary emphasis is on the epidemiology of vector-borne diseases and the bionomics and control of disease vectors. Ecology of vector helps to plan and implement prevention and control measures to protect deployed forces from disease, injury, and annoyance caused by vectors and pests.
To read related article follow us at
Journal home page: http://www.scitechnol.com/vector-biology-journal.php
Enhancement of Infection by Pre-Existing Non-Neutralizing Antibodies to Cross-Reactive Flaviviruses: Ramifications for Vaccination against Dengue and Zika
The arthropod-borne (arbo) viruses dengue (DENV) and Zika (ZIKV) are closely related species of enveloped, positive sense, singlestranded RNA virions of the Flavivirus genus. These important human pathogens belong to the family Flaviviridae that also includes the causative agents of yellow fever, Japanese encephalitis and West Nile encephalitis. Both are transmitted between humans by female mosquitoes of the genus Aedes, principally Ae. aegypti and Ae. albopictus. By virtue of the broad geographical distribution of their common vectors, DENV and ZIKV co-circulate in large parts of the tropics and subtropics. No prophylactic vaccine or therapeutic drug with which to alleviate either infection is presently available or affordable to citizens of low income countries.
Full Text link: https://www.scitechnol.com/peer-review/enhancement-of-infection-by-preexisting-nonneutralizing-antibodies-to-crossreactive-flaviviruses-ramifications-for-vaccination-aga-3Qkq.php?article_id=5781
Journal home page: https://www.scitechnol.com/vaccines-clinical-trials.php